Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSAPREPITANT\FOSAPREPITANT DIMEGLUMINE: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

50.0%
Female
50.0%
Male

Age Information

The average age of patients reporting adverse events with FOSAPREPITANT\FOSAPREPITANT DIMEGLUMINE is 55.5 years.

Geographic Distribution

The majority of adverse event reports for FOSAPREPITANT\FOSAPREPITANT DIMEGLUMINE originate from CA.

Report Summary & Outcomes

13
Total Reports
13
As Primary/Secondary Suspect
6
Deaths Reported
9
Hospitalizations
7
Life-Threatening
4
Disabilities

Reporting Timeline

First adverse event report: 20240418. Most recent report: 20241204. View full timeline →

More About FOSAPREPITANT\FOSAPREPITANT DIMEGLUMINE

FOSAPREPITANT\FOSAPREPITANT DIMEGLUMINE Full Profile Reports by Year Drug Interactions